FIELD: biotechnology.
SUBSTANCE: method of purification of vaccinia virus, including recombinant its recombinant variants, comprises sonication of the original virus-containing liquid. The resulting suspension is centrifuged at 24,000 rev/min. The precipitate is resuspended in the buffer. It is re-sonicated, treated with modified trypsin at a concentration of 50-75 mcg/ml for 10-30 minutes at a temperature of 37°C. Then the suspension is frozen at -20°C. After thawing, the virus-containing suspension is applied to the 36% sucrose solution and centrifuged at 30,000 rev/min, followed by resuspension of the resulting precipitate in the buffer solution. At that for resuspension of the precipitations containing viral particles, 0.05 M Tris-HCl, buffer with pH 9.0 are preferably used. The modified trypsin is used as salt-free trypsin treated with L-(tosylamido-2-phenyl)-ethyl-chloromethyl ketone.
EFFECT: invention enables to speed up and reduce the cost of the process of obtaining of highly purified vaccinia virus, including its recombinant versions.
4 cl, 2 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-TUMOUR AGENT BASED ON RECOMBINANT VACCINIA VIRUS STRAIN AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2730657C1 |
RECOMBINANT MODIFIED VIRUS OF VACCINE ANKARA ABLE TO EXPRESS HEPATITIS C VIRUS STRUCTURAL ANTIGENS | 2002 |
|
RU2270860C2 |
STRAIN OF RECOMBINANT SMALL POX VIRUS EXPRESSING STRUCTURAL PROTEINS OF THE HORSE VENEZUELAN ENCEPHALOMYELITIS VIRUS AND USEFUL FOR IMMUNOBIOLOGICAL PREPARATIONS PRODUCTION AND A METHOD OF ITS PREPARING | 1993 |
|
RU2091489C1 |
METHOD OF PRODUCING ANTIGEN OF ZIKA VIRUS, HAVING IMMUNOGENIC AND ANTIGENIC PROPERTIES | 2019 |
|
RU2717993C1 |
METHOD OF PRODUCTION OF ANTIRABIC VACCINE | 2013 |
|
RU2538617C2 |
RECOMBINANT ONCOLYTIC STRAIN OF THE VACCINIA VIRUS L-IVP_ONCOB, CONTAINING GENES, ENCODING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND POLYEPITOPE IMMUNOGEN, CONSISTING OF EPITOPES OF ANTIGENS, HYPER EXPRESSING BY TUMOR CELLS IN BREAST CANCER | 2017 |
|
RU2678056C1 |
RECOMBINANT ONCOLYTIC STRAIN OF L-IVP_ONCOM VACCINIA VIRUS, CONTAINING GENES, ENCODING GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR AND POLYEPITOPE IMMUNOGEN CONSISTING OF ANTIGEN EPITOPES, OVEREXPRESSING TUMOR CELLS IN MELANOMA | 2017 |
|
RU2678060C1 |
RECOMBINANT MODIFIED SMALLPOX VIRUS, ITS USAGE (VERSIONS) AND CELL LINE INFECTED BY VIRUS (VERSIONS) | 1996 |
|
RU2198217C2 |
METHOD OF PREPARING SURFACE ANTIGEN OF HEPATITIS B VIRUS (HBS AG), MONOCLONAL ANTIBODIES CB-HEPI, SURFACE ANTIGEN OF HEPATITIS B VIRUS (HBS AG) AND METHOD OF PREPARING HYBRID CLONE 48/1/574 PRODUCING MONOCLONAL ANTIBODIES CB-HEPI | 1992 |
|
RU2128707C1 |
RECOMBINANT STRAIN VV-GMCSF-S1/3 OF VACCINIA VIRUS, PRODUCING SECRETED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING HUMAN FACTOR | 2013 |
|
RU2565544C2 |
Authors
Dates
2014-12-27—Published
2013-08-07—Filed